Stem cell therapies in reparative medicine

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


The future implementation of stem cell therapies to treat conditions thus far considered incurable has been envisioned as logical consequence of the fast-paced progress in stem cell research over the last few years. Still, many practical obstacles stand in the way to the routine application of these novel technologies in medicine. The conference "Stem Cell Therapies in Reparative Medicine," held aboard the cruise vessel Majesty of the Seas (Miami, USA- Nassau, Bahamas, April 19-22, 2002), focused on the analysis of these problems from different perspectives, including developmental biology (cell proliferation, fate determination, and enrichment), immunology (allorejection and prevention of autoimmunity recurrence), and clinical therapy, emphasizing the impact of stem cell technologies on the emerging field of tissue engineering and the treatment of alpha-1 antitrypsin deficiency.

Original languageEnglish (US)
Pages (from-to)329-334
Number of pages6
JournalCell Transplantation
Issue number4
StatePublished - Jan 1 2003


  • Alpha-1 antitrypsin
  • Development
  • Diabetes
  • Human embryonic stem cells
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation


Dive into the research topics of 'Stem cell therapies in reparative medicine'. Together they form a unique fingerprint.

Cite this